Last $132.07 USD
Change Today 0.00 / 0.00%
Volume 0.0
BAYZF On Other Exchanges
Symbol
Exchange
OTC US
Xetra
OTC US
BrsaItaliana
Xetra
Mexico
Continuous
As of 8:10 PM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

bayer ag-reg (BAYZF) Snapshot

Open
$134.19
Previous Close
$132.07
Day High
$134.95
Day Low
$132.07
52 Week High
06/2/14 - $145.00
52 Week Low
09/9/13 - $108.85
Market Cap
109.2B
Average Volume 10 Days
908.7
EPS TTM
--
Shares Outstanding
826.9M
EX-Date
04/30/14
P/E TM
--
Dividend
$2.17
Dividend Yield
2.19%
Current Stock Chart for BAYER AG-REG (BAYZF)

bayer ag-reg (BAYZF) Related Bloomberg News

View More Bloomberg News

bayer ag-reg (BAYZF) Details

Bayer Aktiengesellschaft develops, produces, and markets health care and agricultural products, and high-tech polymer materials worldwide. The company operates through HealthCare, CropScience, and MaterialScience segments. The HealthCare segment offers prescription pharmaceuticals, such as contraceptives, hemophilia treatments, anticoagulants, and medicines to treat multiple sclerosis, cancer, hypertension, and infectious diseases; and consumer health products comprising over-the-counter medications, dermatology products, nutritional supplements, veterinary medicines, and animal grooming products. This segment also provides medical care products, including blood glucose monitoring devices, such as single-strip and multi-strip systems; USB meters that feature integrated diabetes management software and direct plug-in to computers; contrast agent injection systems for diagnostic and therapeutic medical procedures in computed tomography, magnetic resonance imaging, and molecular imaging; and mechanical systems for removing thrombi from blood vessels, as well as service products for its systems. The CropScience segment offers products for use in agriculture as insecticides, fungicides, and herbicides or seed treatments; seeds and plant traits; and various products for gardens, green industry, and nonagricultural pest control. The MaterialScience segment provides high-tech polymer materials in the areas of polyurethanes, polycarbonates, coating and adhesive raw materials, and functional films; and produces and markets inorganic basic chemicals. The company has a strategic alliance with OncoMed Pharmaceuticals, Inc. to develop drugs to target cancer stem cell therapeutics. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.

114,928 Employees
Last Reported Date: 04/29/14
Founded in 1863

bayer ag-reg (BAYZF) Top Compensated Officers

Chairman of Management Board and Chief Execut...
Total Annual Compensation: €2.9M
Chief Financial Officer and Member of Managem...
Total Annual Compensation: €1.8M
Labor Director and Member of Management Board
Total Annual Compensation: €1.1M
Compensation as of Fiscal Year 2013.

bayer ag-reg (BAYZF) Key Developments

Bayer to Close Darmstadt Polycarbonate Plant

Bayer is to close its plastic polycarbonate production facility in Darmstadt as a result of market overcapacity and weak demand. The closure will affect 90 employees at the Bayer MaterialScience (BMS) site, with European customers to be supplied from sites in Nera Montoro, Italy, and Tielt, Belgium. The decision to shutter the site follows a review of Bayer's global polycarbonate business, which concluded that customer demand is insufficient to absorb overcapacities exacerbated by the entrance of new competitors into the sector. The company decided that a consolidation of its European polycarbonates operations was necessary to remain competitive.

Bayer AG Presents at Goldman Sachs 35th Annual Global Healthcare Conference, Jun-10-2014

Bayer AG Presents at Goldman Sachs 35th Annual Global Healthcare Conference, Jun-10-2014 . Venue: Terranea Resort in Rancho Palos Verdes, 100 Terranea Way, Los Angeles, California, United States.

Bayer AG Announces Executive Changes

The supervisory board of Bayer AG has appointed Werner Baumann, currently chief financial officer (CFO), as chief strategy and portfolio officer (CSPO), effective October 1, 2014. At the same time, the company appointed Johannes Dietsch as substitute for Baumann, also effective October 1, 2014. Prior to becoming CFO, Dietsch had been a senior Bayer representative and CFO for Greater China.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BAYZF:US $132.07 USD 0.00

BAYZF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AstraZeneca PLC 4,341 GBp -20.00
Cie de St-Gobain €36.76 EUR -0.175
GlaxoSmithKline PLC 1,421 GBp +6.00
Sanofi €76.64 EUR +0.31
Unilever PLC 2,638 GBp +8.00
View Industry Companies
 

Industry Analysis

BAYZF

Industry Average

Valuation BAYZF Industry Range
Price/Earnings 23.1x
Price/Sales 2.0x
Price/Book 3.8x
Price/Cash Flow 23.1x
TEV/Sales 1.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BAYER AG-REG, please visit www.bayer.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.